Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

NCT02038972 is registered in ClinicalTrials.gov with James Baumgartner, MD as lead sponsor.

NCT NCT02038972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02038972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Lead sponsor
James Baumgartner, MD
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2013
Completion date
January 10, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sensorineural hearing loss